IN RE: GENERIC PHARMACEUTICALS PRICING ANTITRUST LITIGATION
Case Number:
2:16-md-02724
Court:
Nature of Suit:
Multi Party Litigation:
Class Action, Multi-district Litigation
Judge:
Firms
- Sarraf Gentile
- Andrus Anderson
- Dechert LLP
- Edelson Lechtzin
- Shipman & Goodwin
- Krantz & Berman
- McCune Law
- Fiddler Gonzalez
- Berman Tabacco
- Lieff Cabraser
- Barnes & Thornburg
- Ahern & Associates
- Anselmi & Carvelli
- Harkins Cunningham
- Axinn Veltrop
- Cicala Law Firm
- Burns Charest
- Armstrong Teasdale
- Levin Sedran
- Kohn Swift
- Steptoe LLP
- Motley Rice
- Tostrud Law Group
- Gross & Belsky
- Dilworth Paxson
- Freedman Boyd
- Obermayer Rebmann
- Girard Sharp
- Steyer Lowenthal
- Foley & Lardner
- Cera LLP
- Saiber LLC
- Crowell & Moring
- Stradley Ronon
- Faegre Drinker
- Lockridge Grindal
- Rosenn Jenkins
- Barrack Rodos
- Schneider Wallace
- Hach Rose Schirripa
- Cuneo Gilbert
- Kirkland & Ellis
- Welsh & Recker
- DeCotiis FitzPatrick
- Pendley Baudin
- Shapiro Arato
- Lite DePalma
- Hogan Lovells
- Bailey & Glasser
- Joseph Saveri Law Firm
- Competition Law Partners
- Zwerling Schachter
- McConnell Valdes
- Safirstein Law
- Stueve Siegel
- Dugan Law Firm
- Neufeld Scheck
- Spector Roseman
- Wexler Boley
- Goldman Scarlato
- Heins Mills
- Berry Law LLC
- Seeger Weiss
- Zelle LLP
- Hunt Ortmann
- King & Spalding
- Hughes Hubbard
- Ricci Tyrrell
- Schertler Onorato
- Fenwick & West
- Wiggin & Dana
- Faruqi & Faruqi
- Shinder Cantor
- Reed Smith
- Debevoise & Plimpton
- Roberts Law Firm US
- Kasowitz Benson
- Walsh Pizzi
- Boni Zack
- Lyden Chappell
- Simpson Thacher & Bartlett LLP
- Segal McCambridge
- Calcaterra Pollack
- Patterson Belknap
- Hagens Berman
- Bonsignore Trial Lawyers
- Buchanan Ingersoll
- Napoli Shkolnik
- Carella Byrne
- McCracken Stemerman
- Wisner Baum
- Manatt Phelps
- George Feldman
- Bailey Duquette
- Winston & Strawn
- Francis Mailman
- Boies Schiller
- O'Melveny & Myers
- Baker & Hostetler
- Neal & Harwell
- Nussbaum Law Group
- White and Williams
- Kaplan Fox
- Cleary Gottlieb
- Marks O'Neill
- Tycko & Zavareei
- Zuckerman Spaeder
- Barrett Law Group
- Troutman
- Duane Morris
- Williams & Connolly
- Cozen O'Connor
- Scott&Scott
- Miller & Chevalier
- Law Offices of Francis O. Scarpulla
- Petrillo Klein
- Larson King
- Hausfeld LLP
- Kralowec Law
- Furth Salem
- Greenberg Traurig
- Haynes Boone
- Langer Grogan
- Lewis Brisbois
- Weil Gotshal
- Hangley Aronchick
- Gibson Dunn
- Pullman & Comley
- Grabar Law
- Stevens & Lee
- Sills Cummis
- NastLaw
- Berger Montague
- Skadden Arps
- Rule Garza
- Garwin Gerstein
- DiCello Levitt
- Radice Law Firm
- Yarborough Law Firm
- Bartlit Beck
- Kelley Drye
- Proskauer Rose
- Morgan Lewis
- Wolf Haldenstein
- Arnold & Porter
- Tarter Krinsky
- Cotchett Pitre
- Taus Cebulash
- Spiro Harrison
- Paul Weiss
- Lowey Dannenberg
- Steven Williams Law
- DLA Piper
- Freshfields
- Norton Rose
- Bingham McCutchen
- Lowenstein Sandler
- Ballard Spahr
- Cole Schotz
- Gustafson Gluek
- Baker Botts
- Goodwin Procter
- Clark Hill
- Wilson Sonsini
- Seward & Kissel
- Whatley Kallas
- Miller Shah
- Cohen Milstein
- Morrison Foerster
- Robbins Geller
- O’Neill & Borges
- Sperling Kenny
- Earp Cohn
- McDermott Will & Emery
- Zimmerman Reed
- Glancy Prongay
- Harris St. Laurent
- Constantine Cannon
- K&L Gates
- Fox Rothschild
- Polsinelli PC
- Venable LLP
- Blank Rome
- WilmerHale
- Linklaters LLP
- Fine Kaplan
- Grant & Eisenhofer
- Labaton Keller
- Saveri & Saveri
- Curtis Mallet-Prevost
- Latham & Watkins
- White & Case
Companies
- Sun Pharmaceutical Industries Ltd.
- Perrigo Co. PLC
- Sandoz International GmbH
- Impax Laboratories, Inc.
- MSP Recovery
- Walgreens Boots Alliance Inc.
- Novartis AG
- Endo International PLC
- Aurobindo Pharma Ltd.
- The Harvard Drug Group LLC
- Lupin Ltd.
- Amneal Pharmaceuticals Inc.
- Lannett Company, Inc
- Health Care Service Corp.
- Taro Pharmaceutical Industries Ltd.
- Bi-Lo
- The Cigna Group
- Viatris Inc.
- Humana Inc.
- Hi-Tech Pharmacal Co., Inc.
- Molina Healthcare Inc.
- Allergan PLC
- Par Pharmaceutical Cos. Inc.
- Dr. Reddy's Laboratories Ltd.
- Fougera Pharmaceuticals Inc.
- United Food & Commercial Workers International Union
- Bausch Health Cos. Inc.
- Alvogen Group Inc.
- West-Ward Pharmaceutical Corp.
- Cadila Pharmaceuticals Ltd.
- Ascend Laboratories LLC
- Emcure Pharmaceuticals Ltd.
- Akorn Inc.
- Cardinal Health Inc.
- Avet Pharmaceuticals Inc.
- Camber Pharmaceuticals Inc.
- McKesson Corp.
- Glenmark Pharmaceuticals Ltd.
- Red Oak Sourcing LLC
- Zydus Pharmaceuticals Inc.
- International Union Of Operating Engineers
- Cencora Inc.
- G&W Laboratories Inc.
- Upsher-Smith Laboratories Inc.
- Rite Aid Corp.
- Winn-Dixie Stores, Inc.
- Wockhardt Ltd.
- Wockhardt USA LLC
- Pfizer Inc.
- Jubilant Cadista
- American Federation of State County & Municipal Employees
- Teva Pharmaceutical Industries Ltd.
Government Agencies
Sectors & Industries:
-
May 07, 2021
Dermatology Case Tapped As Bellwether In Generic Drug MDL
A Pennsylvania federal judge has selected a case from state enforcers over dermatology treatments to serve as a bellwether in the multidistrict litigation over price-fixing in the generic-drug industry.
-
May 05, 2021
Generic-Drug Makers Knock States' Objection To Sanctions
Generic-drug makers accused of participating in an industrywide price-fixing scheme are urging a Pennsylvania federal court to disregard state enforcers' objections to a special master's recommendation to sanction the California attorney general's office for failing to fulfill discovery obligations in the multidistrict litigation.
-
April 27, 2021
AGs Warn Against Sanctioning Calif. In Generics Pricing MDL
The attorneys general of Pennsylvania, Oregon and Minnesota urged a Pennsylvania federal judge to reject a special master's recommendation to sanction the California Attorney General's Office for failing to fulfill discovery obligations in multidistrict litigation over inflated medication prices, arguing that it has broad implications.
-
April 07, 2021
States Too Late To Question Report In MDL, Drugmakers Say
A coalition of generic-drug companies filed an opposition brief on Wednesday blasting a group of state attorneys general for contesting a special master's recommendation in sprawling multidistrict litigation accusing much of the generic-drug industry of price-fixing, arguing that the states' motion is untimely.
-
April 06, 2021
Calif. AG Says Sanctions Rec. 'Misunderstands' Generics MDL
The California Attorney General's Office said a special master went too far in recommending sanctions against it for not living up to discovery obligations in a multidistrict litigation that accuses much of the generic-drug industry of price-fixing, saying Monday all the material is coming from the defendant drugmakers and third parties.
-
March 30, 2021
Generics Cos. Argue For Heritage Bellwether In Antitrust MDL
A group of generic-drug makers facing multiple antitrust complaints for allegedly working in concert to inflate medication prices has urged a Pennsylvania federal judge to choose a case against Heritage Pharmaceuticals as the bellwether.
-
March 23, 2021
Generics MDL Special Master Says Calif. AG Merits Sanctions
A special master on Monday recommended that the California Attorney General's Office be sanctioned for failing to live up to discovery promises in the sprawling multidistrict litigation that accuses much of the generic drug industry of price-fixing, saying the office should be limited to only evidence that was produced on deadline.
-
March 17, 2021
States Push New Bellwether Generic Drug Price-Fixing Case
If a Pennsylvania federal judge wants to swap out the bellwether case in sprawling litigation that accuses much of the generic drug industry of price-fixing, a coalition of attorneys general want her to choose a different state-brought case than the one she's currently considering as a replacement.
-
March 02, 2021
Teva, Mylan Back Plan For New Bellwether In Price-Fix MDL
Mylan, Teva and Par Pharmaceuticals are among a group of generic-drug makers that told a Pennsylvania federal judge Monday they're fine with her plan to swap out a bellwether case in multidistrict litigation that accuses most of the generics industry of price-fixing.
-
February 09, 2021
Teva-Centric Price-Fix Case Likely To Lose Bellwether Status
A Pennsylvania federal judge said Tuesday she was "no longer convinced" that a price-fixing lawsuit centered around Teva from state attorneys general should serve as a bellwether trial for multidistrict litigation accusing most of the generic-drug industry of price-fixing, thanks to related criminal charges against the company.